⌕
Tandem Diabetes Care · TNDM · Nasdaq
Tenet 33 · Weak
Compare
$20.07+14.62%At closeTenet 33 · Weak
$20.07+2.56 (+14.62%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Tandem Diabetes Care (TNDM) Stock

Tandem Diabetes Care (TNDM) closed at $20.07 on Nov 13, 2026; its Tenet Score is 33 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

19 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$20.07
Nov 13, 2026
Market cap
$1.4B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
12.26 – 29.65
low → high
Tenet Score
33/100
Weak · 409 Healthcare peers

Industry: Health Services · see every company filed here →

Tandem Diabetes Care Inc scores 33/100. Weak. Value is the soft spot versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
33/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
16
Quality
34
Health
33
Growth
48

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityDHealthDGrowthDMomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
10.4×
price to book value
P/S
1.3×
price to fiscal 2025 sales
ROE
−37%
return on equity
Operating margin
−18.5%
fiscal 2025, before interest and tax
Net margin
−4.6%
of revenue kept
Current ratio
3.21
current assets to liabilities
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin deliver…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 87 US ETFs · top wrappers by weightSee all ETFs holding TNDM →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

Compare Tandem Diabetes Care with

What sector and industry is Tandem Diabetes Care in?

Tandem Diabetes Care is in the Healthcare sector and the Health Services industry.

What is Tandem Diabetes Care's Tenet Score?

Tandem Diabetes Care's Tenet Score is 33 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.